The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 332.00
Bid: 333.60
Ask: 334.00
Change: -0.80 (-0.24%)
Spread: 0.40 (0.12%)
Open: 333.20
High: 334.00
Low: 328.20
Prev. Close: 332.80
ROR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Bifold Group

28 Aug 2015 07:00

RNS Number : 4052X
Rotork PLC
28 August 2015
 

28 August 2015

 

Rotork plc

 

Acquisition of Bifold Group

 

Rotork p.l.c. ("Rotork"), the market leading actuator manufacturer and global flow control company, announces that it has acquired Bifold Group Limited ("Bifold") for up to £125m on a cash-free and debt-free basis.

 

Bifold is a leading manufacturer of pneumatic and hydraulic instrument valves and components focused on the oil and gas industry and wider industrial markets, with expertise in a number of niche sectors such as subsea and wellhead control systems. It also has market leading technology in areas that include the development of solenoid valves with ultra-low power requirements.

 

Bifold is headquartered in Manchester, UK, and employs approximately 300 people across its operations in Manchester and Taunton, UK. The company is being acquired from a consortium including LDC, current management and other shareholders. Bifold will sit within Rotork's Instruments division and its current management team will remain with the business. 

 

The acquisition is in line with Rotork's strategy of strengthening its presence in the flow control market and broadening its product portfolio. Bifold has a strong market presence and excellent brand recognition within its end markets. Rotork estimates that the addition of Bifold will significantly increase Rotork's addressable market by approximately £750m to £4.3bn. As part of Rotork, Bifold will also be able to offer a broader product portfolio to its customers.

 

In the 12 months to 31 August 2014, Bifold generated EBITDA of £10.2m on revenue of £41.0m1. For the 12 months to 31 August 2015, Bifold is anticipated to generate EBITDA of £7.6m on revenue of £37.7m, reflecting the current market weakness. Whilst the current market remains challenging, and is anticipated to remain so in the short term, the timing of this acquisition will allow us to position the company for the long term growth opportunities this market presents.

 

The total consideration is for up to £125m in cash, comprising £115m on completion and £10m deferred for up to 2 years based on achieving specific financial targets. The acquisition is being financed from new committed debt facilities.

 

Commenting on the acquisition, Peter France, Chief Executive, said:

 

"The acquisition of Bifold represents an exciting step forward in the continued development of Rotork Instruments. This strategic acquisition of a long held target of Rotork's is directly in line with our core strategy of strengthening Rotork's presence in the flow control sector and broadening our product portfolio.

 

Bifold is a highly complementary business to Rotork with a well-regarded management team that provides Rotork with an enlarged platform to further offer its products and services to the oil and gas sector and wider industrial markets. The combination of Bifold's extensive product portfolio and leading technology with Rotork's international sales network and geographic reach will significantly strengthen our presence across the global flow control market."

 

 

Footnote

1. The 2014 results stated above are on a management basis and best represent the ongoing performance of the business under Rotork ownership. The statutory accounts for August 2014 reported revenue of £41.1m with operating profit of £6.6m, a loss before taxation of £2.0m and gross assets of £40.6m.

 

 

Conference call

 

Peter France, Chief Executive, and Jonathan Davis, Finance Director, will be hosting a conference call for analysts and investors at 8.30am today to discuss the acquisition. A short presentation will be made available on the company's website: http://www.rotork.com. To join the call, please dial in to the following number:

 

UK number +44 (0)203 139 4830

UK toll free number 0808 237 0030

Participant PIN 93209678#

 

A recording will be available shortly after the conclusion of the call on the following numbers:

UK number +44 (0)20 3426 2807

UK toll free number 0808 237 0026

Conference reference 661277#

 

 

For further information, please contact:

 

 

 

Rotork p.l.c.

Tel: 01225 733200

Peter France, Chief Executive

 

Jonathan Davis, Finance Director

 

 

 

FTI Consulting

Tel: 020 3727 1340

Nick Hasell / Susanne Yule

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQMMGZRKRKGKZG
Date   Source Headline
2nd Apr 20245:56 pmRNSTransaction in Own Shares
2nd Apr 20244:15 pmRNSTotal Voting Rights
2nd Apr 20243:00 pmRNSDirector/PDMR Shareholding
28th Mar 20245:46 pmRNSTransaction in Own Shares
27th Mar 20246:09 pmRNSTransaction in Own Shares
26th Mar 20245:55 pmRNSTransaction in Own Shares
26th Mar 20245:28 pmRNSDirector/PDMR Shareholding
26th Mar 20242:18 pmRNS2023 Annual Report and Notice of 2024 AGM
25th Mar 20245:35 pmRNSTransaction in Own Shares
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
22nd Mar 20245:51 pmRNSTransaction in Own Shares
21st Mar 20246:17 pmRNSTransaction in Own Shares
21st Mar 20247:00 amRNSShare Buy-Back Programme
19th Mar 202410:30 amRNSHolding(s) in Company
12th Mar 20244:00 pmRNSDirector/PDMR Shareholding
11th Mar 20243:29 pmRNSDirector/PDMR Shareholding
5th Mar 20247:01 amRNSShare buy-back programme
5th Mar 20247:00 amRNS2023 Preliminary Results
1st Mar 20243:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
13th Feb 20243:30 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
11th Jan 20243:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:00 amRNSTotal Voting Rights
20th Dec 20235:17 pmRNSDirector Declaration
13th Dec 20233:30 pmRNSDirector/PDMR Shareholding
13th Dec 202311:00 amRNSDirector Declaration
11th Dec 20233:30 pmRNSDirector/PDMR Shareholding
1st Dec 20233:30 pmRNSTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
13th Nov 20233:30 pmRNSDirector/PDMR Shareholding
1st Nov 20233:00 pmRNSTotal Voting Rights
11th Oct 20233:30 pmRNSDirector/PDMR Shareholding
9th Oct 20233:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSTotal Voting Rights
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSDirectorate Change – CFO Transition
7th Sep 202311:45 amRNSDirectorate Change
4th Sep 20234:03 pmRNSTotal Voting Rights
14th Aug 20234:30 pmRNSDirector/PDMR Shareholding
8th Aug 20237:00 amRNS2023 Interim Results
1st Aug 20234:36 pmRNSTotal Voting Rights
11th Jul 20233:00 pmRNSDirector/PDMR Shareholding
3rd Jul 202311:30 amRNSTotal Voting Rights
29th Jun 202310:45 amRNSDirectorate Change
19th Jun 202311:00 amRNSDirector Declaration
14th Jun 20233:30 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirector/PDMR Shareholding
8th Jun 202312:26 pmRNSTotal Voting Rights
15th May 20234:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.